✦ LIBER ✦

P-218 A phase II study of cisplatin and docetaxel administered as 3 consecutive weekly infusions for advanced NSCLC in elderly patients

✍ Scribed by Ohe, Yuichiro; Niho, Seiji; Watanabe, Koshiro; Yokoyama, Akira; Saijo, Nagahiro; Nishiwaki, Yutaka

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of docetaxel and cisplati

✍ Niho, Seiji; Ohe, Yuichiro; Kakinuma, Ryutaro; Kubota, Kaoru; Matsumoto, Taketos 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Lower recommended dose but not diminishe

✍ Ohe, Y; Niho, S; Kakinuma, R; Kubota, K; Matsumoto, T; Ohmatsu, H; Goto, K; Mori 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 222 KB

P-45 A phase II study of weekly docetaxe

✍ Minato, Koichi; Tsuchiya, Satoshi; Ishihara, Shin-ichi; Watanabe, Satoru; Takei, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB

550 Phase I and pharmacokinetic (PK) stu

✍ S.Q. Chu; G. Schwartz; M. Beeram; A. Patniak; M. Mita; J. Jimeno; L. Lopez-Laraz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Evaluation of the safety of C-1311 (SYMA

✍ N. Isambert; M. Campone; E. Bourbouloux; M. Drouin; A. Major; W. Yin; P. Loadman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 124 KB

O-110 Preliminary results of a phase II

✍ Gadgeel, Shirish M.; Shehadeh, Nasfet; Kraut, Michael J.; Wozniak, Antoinette; B 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB